Rua Bioscience Limited (NZE:RUA)
0.0380
-0.0010 (-2.56%)
Sep 11, 2026, 3:44 PM NZST
Rua Bioscience Cash Flow Statement
Financials in millions NZD. Fiscal year is July - June.
Millions NZD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -3.36 | -3.46 | -13.72 | -5.96 | -8.64 |
Depreciation & Amortization | 0.41 | 0.4 | 0.4 | 0.68 | 0.81 |
Loss (Gain) From Sale of Assets | 0.01 | -0.07 | -0 | 0.01 | -0 |
Asset Writedown & Restructuring Costs | 0.02 | 0.04 | 9.21 | 5.57 | - |
Stock-Based Compensation | 0.21 | 0.04 | 0.37 | 0.09 | -0.14 |
Other Operating Activities | 0.19 | 0.15 | -0.11 | -6 | 1.07 |
Change in Accounts Receivable | -0.18 | -0.05 | 0.59 | -0.29 | 0.1 |
Change in Inventory | -0.24 | -0.05 | -0.26 | 0.15 | -0.24 |
Change in Accounts Payable | 0.22 | 0.19 | 0.03 | 0.09 | 0 |
Change in Unearned Revenue | - | -0.07 | 0.06 | 0 | 0.01 |
Change in Other Net Operating Assets | -0.23 | 0.08 | -0.31 | -0.28 | 0.17 |
Operating Cash Flow | -2.96 | -2.79 | -3.74 | -5.92 | -6.84 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0 | -0 | -0 | -0.07 | -0.4 |
Sale of Property, Plant & Equipment | 0 | 0.11 | 0.05 | 0.03 | 0 |
Cash Acquisitions | - | - | - | - | 0.88 |
Investment in Securities | - | - | 2 | 6 | 5 |
Other Investing Activities | 0.01 | 0 | 0.16 | 0.71 | 0.11 |
Investing Cash Flow | 0.01 | 0.11 | 2.21 | 6.67 | 5.59 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | 2.34 | 1.29 | - | - | - |
Total Debt Issued | 2.34 | 1.29 | - | - | - |
Short-Term Debt Repaid | -1.57 | -0.69 | - | - | - |
Long-Term Debt Repaid | -0.04 | -0.08 | -0.08 | -0.1 | -0.16 |
Lease Payments | -0.04 | -0.08 | -0.08 | -0.1 | -0.15 |
Total Debt Repaid | -1.61 | -0.77 | -0.08 | -0.1 | -0.16 |
Net Debt Issued (Repaid) | 0.72 | 0.51 | -0.08 | -0.1 | -0.16 |
Issuance of Common Stock | 2.89 | 1.68 | - | - | - |
Other Financing Activities | -0.37 | -0.18 | -0.02 | -0.02 | -0.04 |
Financing Cash Flow | 3.24 | 2.02 | -0.09 | -0.12 | -0.21 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | 0.01 | 0.01 | -0.01 | - | - |
Net Cash Flow | 0.29 | -0.65 | -1.63 | 0.63 | -1.46 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -2.96 | -2.79 | -3.74 | -5.99 | -7.25 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -101.32% | -152.79% | -1181.50% | -896.65% | -1123.09% |
Free Cash Flow Per Share | - | -0.01 | -0.02 | -0.04 | -0.05 |
Levered Free Cash Flow | -2.14 | -1.62 | -2.9 | -6.93 | -1.53 |
Unlevered Free Cash Flow | -1.94 | -1.52 | -2.89 | -6.92 | -1.5 |
Free Cash Flow After Leases | -3.01 | -2.87 | -3.82 | -6.1 | -7.4 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | - | 0.03 | 0.02 | 0.02 | 0.04 |
Change in Working Capital | -0.43 | 0.1 | 0.11 | -0.32 | 0.05 |